Intercept Pharmaceuticals Inc. (ICPT) Enters Overbought Territory - Tale of the Tape


Shutterstock photo

Intercept Pharmaceuticals Inc. ( ICPT ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ICPT is now in overbought territory with an RSI value of 71.5 . Furthermore, Intercept Pharmaceuticals Inc. currently has a Zacks Rank #4 (Sell) , suggesting that investors may want to consider exiting this stock now before it falls back to Earth.

INTERCEPT PHARM (ICPT): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ICPT

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by